Interestingly, patients with International Neuroblastoma Staging System (INSS) stage 4S, which is characterized by a favorable outcome [22], demonstrated lower expression of leptin compared to INSS stage 4 high-risk neuroblastoma patients (Figure 2A). Here, LEP is linked to neuroblastoma.